What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?

Enrico De Lorenzis; Gerlando Natalello; Laura Gigante; Lucrezia Verardi; Silvia Laura Bosello; Elisa Gremese

doi:10.1016/j.autrev.2020.102666

What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?

Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello, Elisa Gremese

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	102666-N/A
Rivista	Autoimmunity Reviews
Volume	19
DOI	https://doi.org/10.1016/j.autrev.2020.102666
Stato di pubblicazione	Pubblicato - 2020

Keywords

Anti-MDA5
COVID-19
Interstitial lung disease
Dermatomyositis
Inflammation
Cytokines

Accesso al documento

10.1016/j.autrev.2020.102666

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{46a2eb806d034e68a2ac40c8ec9c97ff,

title = "What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?",

keywords = "Anti-MDA5, COVID-19, Interstitial lung disease, Dermatomyositis, Inflammation, Cytokines, Anti-MDA5, COVID-19, Interstitial lung disease, Dermatomyositis, Inflammation, Cytokines",

author = "{De Lorenzis}, Enrico and Gerlando Natalello and Laura Gigante and Lucrezia Verardi and Bosello, {Silvia Laura} and Elisa Gremese",

year = "2020",

doi = "10.1016/j.autrev.2020.102666",

language = "English",

volume = "19",

pages = "102666--N/A",

journal = "Autoimmunity Reviews",

issn = "1568-9972",

publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: [email protected], [email protected], INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",